FdaApplication
ANDA 205407
Identifiers
- fda_app_no: ANDA205407
Properties
| Property | Value |
|---|---|
| applicant_name | JUBILANT GENERICS LTD |
| application_type | ANDA |
| approval_date | 2015-12-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 40MG BASE | TABLET;ORAL |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 20MG BASE | TABLET;ORAL |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE | EQ 10MG BASE | TABLET;ORAL |
3 products